Recurrent pelvic intravenous leiomyomatosis

Area of Science:

• Gynecologic Oncology
• Pathology
• Reproductive Endocrinology

Background:

• Intravenous leiomyomatosis (IVL) is a rare neoplastic condition characterized by benign smooth muscle tumors within venous channels, predominantly affecting the female pelvis.
• Recurrence of IVL is exceptionally uncommon, with only two prior documented instances.
• Understanding the factors contributing to IVL recurrence is crucial for effective patient management.

Observation:

• This report details two novel cases of recurrent intravenous leiomyomatosis.
• In three out of the four total cases (including the new ones), functioning ovarian tissue was present at the time of tumor recurrence.
• These observations suggest a potential link between endogenous estrogen and the recurrence of IVL.

Findings:

• The presence of functioning ovarian tissue alongside recurrent IVL in a majority of observed cases points towards a possible hormonal influence.
• Endogenous estrogen may play a significant role in the pathogenesis or promotion of IVL recurrence.
• The findings support the hypothesis that hormonal factors contribute to the neoplastic behavior of IVL.

Implications:

• Therapeutic strategies for intravenous leiomyomatosis should consider the potential role of estrogen.
• Bilateral oophorectomy (surgical removal of both ovaries) is proposed as a critical component of treatment to mitigate recurrence risk.
• Further research into the hormonal dependencies of IVL is warranted to refine treatment protocols and improve patient outcomes.